Cell MedX (OTCMKTS:CMXC – Get Free Report) is one of 116 publicly-traded companies in the “Medical Devices” industry, but how does it compare to its peers? We will compare Cell MedX to related companies based on the strength of its earnings, risk, profitability, institutional ownership, dividends, valuation and analyst recommendations. Insider & Institutional Ownership 27.1% […]
Cell MedX (OTCMKTS:CMXC – Get Free Report) is one of 146 public companies in the “Medical Devices” industry, but how does it weigh in compared to its rivals? We will compare Cell MedX to related businesses based on the strength of its profitability, earnings, analyst recommendations, risk, dividends, institutional ownership and valuation. Insider & Institutional […]
PAVmed (NASDAQ:PAVM – Free Report) and Cell MedX (OTCMKTS:CMXC – Free Report) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, earnings, valuation, risk and dividends. Valuation & Earnings This table compares PAVmed and Cell MedX’s revenue, […]
Cell MedX Amends Loan Agreements, Provides Update on Financing and Regulatory Compliance streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Carson City, Nevada (Newsfile Corp. - October 18, 2022) - Cell MedX Corp. (OTC Pink: CMXC) ("Cell MedX" or the "Company"), a biotech company focusing on the discovery, development and commercialization